
THIS ARTICLE IS AVAILABLE TO CPI SUBSCRIBERS
Please verify email or join us to access premium content!
The final issue in our health series brings in a global perspective. Four of our authors take a look at the EU approach to pharm.; in particular, at the Italian Pfizer case, the Boehringer decision, and court developments since Astra-Zeneca: Is there a pattern? Back in the U.S. we wonder if K-Dur will force the Supreme Court […]

Please verify email or join us to access premium content!